Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

shutterstock_146497481

Gene-editing tool CRISPR found to cause unintentional mutations in live animal models

May 30, 2017 Manufacturing and Production, Research and Development crispr

Gene-editing has been heralded as a wonder tool which could lead to huge advances in a wide range of treatment …
News

Global Pricing Innovations and Pricing360 announce new strategic partnership

May 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …
News
Press release
dr

WHO elects first African Director General

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …
News
liz-new_photo_-_may_2016_jpeg_small

Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients

May 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Takeda oncology, patient advocacy

As published in the special Market Access section of the latest issue of Pharmafocus, Liz Lewis, Chief Counsel & Compliance …
Feature
shutterstock_212432119

Neurocrine’s Ingrezza flops in Tourette’s for second time

May 25, 2017 Research and Development, Sales and Marketing Neurocrine Biosciences, tourette's

Neurocrine’s Tourette’s therapy Ingrezza (valbenazine) has been hit with yet another setback, flopping in a Phase 2 trial of paediatric …
News
epilepsy-623346_960_720

Cannabidiol drug found to aid in devastating childhood epilepsy condition

May 25, 2017 Research and Development GW Pharmaceuticals, cannabidoil, epilepsy

A treatment derived from cannabis has been found to produce remarkable results in children who have epilepsy. Cannabidoil, when offered …
News
hiv

Inovio posts “exceptional” results for HIV vaccine

May 25, 2017 Research and Development AIDS, HIV, HIV vaccine, Vaccine

Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
News
keytruda3-web

MSD receives first FDA approval based on specific genetic feature

May 24, 2017 Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda

In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
News
syringe-1973129_960_720

Antibiotics found to fail in quarter of pneumonia patients

May 24, 2017 Research and Development Antibiotics, antibiotic resistance, pneumonia

A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …
News
merckincweb1

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017 Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
News
scott_gottlieb

Opioid crisis “highest initial priority” for new FDA Commissioner

May 24, 2017 Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis

Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …
News
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!
News

European approval for novel Eisai epilepsy monotherapy

May 23, 2017 Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy

Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
News
2919193_kenneth

Nativis Incorporated appoints new CSO

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025